nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.359	0.535	CrCrCtD
Nandrolone decanoate—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.312	0.465	CrCrCtD
Nandrolone decanoate—Benign prostatic hyperplasia—Tiotropium—chronic obstructive pulmonary disease	0.0313	0.145	CcSEcCtD
Nandrolone decanoate—Hoarseness—Tiotropium—chronic obstructive pulmonary disease	0.0124	0.0572	CcSEcCtD
Nandrolone decanoate—Hoarseness—Salbutamol—chronic obstructive pulmonary disease	0.00941	0.0436	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.00773	0.0358	CcSEcCtD
Nandrolone decanoate—Water retention—Prednisone—chronic obstructive pulmonary disease	0.0076	0.0352	CcSEcCtD
Nandrolone decanoate—Dysphonia—Tiotropium—chronic obstructive pulmonary disease	0.0066	0.0306	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Arformoterol—chronic obstructive pulmonary disease	0.00608	0.0282	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Formoterol—chronic obstructive pulmonary disease	0.00608	0.0282	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.00569	0.0592	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Arformoterol—chronic obstructive pulmonary disease	0.00533	0.0247	CcSEcCtD
Nandrolone decanoate—Dysphonia—Formoterol—chronic obstructive pulmonary disease	0.00533	0.0247	CcSEcCtD
Nandrolone decanoate—MAOA—Serotonin Transporter Activity—SLC6A4—chronic obstructive pulmonary disease	0.0053	0.0551	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Salbutamol—chronic obstructive pulmonary disease	0.00503	0.0233	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.00431	0.0449	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of steroid hormones and vitamin D—GC—chronic obstructive pulmonary disease	0.00427	0.0445	CbGpPWpGaD
Nandrolone decanoate—Hirsutism—Prednisolone—chronic obstructive pulmonary disease	0.00409	0.0189	CcSEcCtD
Nandrolone decanoate—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00399	0.0185	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—SOD3—chronic obstructive pulmonary disease	0.00392	0.0408	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00391	0.0181	CcSEcCtD
Nandrolone decanoate—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00298	0.0138	CcSEcCtD
Nandrolone decanoate—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.00297	0.0137	CcSEcCtD
Nandrolone decanoate—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00287	0.0133	CcSEcCtD
Nandrolone decanoate—Acne—Prednisolone—chronic obstructive pulmonary disease	0.00282	0.0131	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—GCLC—chronic obstructive pulmonary disease	0.00255	0.0266	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00246	0.0114	CcSEcCtD
Nandrolone decanoate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00245	0.0113	CcSEcCtD
Nandrolone decanoate—MAOB—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00243	0.0253	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00234	0.0108	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.00233	0.0242	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00226	0.0105	CcSEcCtD
Nandrolone decanoate—Fluid retention—Prednisolone—chronic obstructive pulmonary disease	0.00225	0.0104	CcSEcCtD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.00221	0.0229	CbGpPWpGaD
Nandrolone decanoate—Acne—Prednisone—chronic obstructive pulmonary disease	0.00205	0.0095	CcSEcCtD
Nandrolone decanoate—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.0095	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00198	0.00919	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00198	0.00919	CcSEcCtD
Nandrolone decanoate—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.00196	0.00909	CcSEcCtD
Nandrolone decanoate—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00194	0.009	CcSEcCtD
Nandrolone decanoate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00194	0.009	CcSEcCtD
Nandrolone decanoate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00194	0.00899	CcSEcCtD
Nandrolone decanoate—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00194	0.00898	CcSEcCtD
Nandrolone decanoate—MAOA—Serotonin Transporter Activity—IL1B—chronic obstructive pulmonary disease	0.00193	0.02	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00868	CcSEcCtD
Nandrolone decanoate—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00183	0.00848	CcSEcCtD
Nandrolone decanoate—MAOB—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00177	0.0184	CbGpPWpGaD
Nandrolone decanoate—MAOA—Oxidative Stress—HMOX1—chronic obstructive pulmonary disease	0.00177	0.0184	CbGpPWpGaD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00171	0.0178	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00766	CcSEcCtD
Nandrolone decanoate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00766	CcSEcCtD
Nandrolone decanoate—Fluid retention—Prednisone—chronic obstructive pulmonary disease	0.00164	0.00759	CcSEcCtD
Nandrolone decanoate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00163	0.00756	CcSEcCtD
Nandrolone decanoate—MAOA—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.0016	0.0167	CbGpPWpGaD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.00159	0.0166	CbGpPWpGaD
Nandrolone decanoate—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00156	0.00724	CcSEcCtD
Nandrolone decanoate—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00156	0.00724	CcSEcCtD
Nandrolone decanoate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00724	CcSEcCtD
Nandrolone decanoate—MAOA—Oxidative Stress—CYP1A1—chronic obstructive pulmonary disease	0.00156	0.0162	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00713	CcSEcCtD
Nandrolone decanoate—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00153	0.0071	CcSEcCtD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00149	0.0155	CbGpPWpGaD
Nandrolone decanoate—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00684	CcSEcCtD
Nandrolone decanoate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00673	CcSEcCtD
Nandrolone decanoate—MAOB—respiratory system—chronic obstructive pulmonary disease	0.0014	0.096	CbGeAlD
Nandrolone decanoate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00635	CcSEcCtD
Nandrolone decanoate—CYP19A1—connective tissue—chronic obstructive pulmonary disease	0.00131	0.0898	CbGeAlD
Nandrolone decanoate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.006	CcSEcCtD
Nandrolone decanoate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.006	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00125	0.013	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00576	CcSEcCtD
Nandrolone decanoate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00576	CcSEcCtD
Nandrolone decanoate—MAOB—connective tissue—chronic obstructive pulmonary disease	0.00123	0.0845	CbGeAlD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00123	0.0128	CbGpPWpGaD
Nandrolone decanoate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00566	CcSEcCtD
Nandrolone decanoate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00565	CcSEcCtD
Nandrolone decanoate—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00122	0.00565	CcSEcCtD
Nandrolone decanoate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00564	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.0012	0.0125	CbGpPWpGaD
Nandrolone decanoate—MAOA—respiratory system—chronic obstructive pulmonary disease	0.0012	0.0819	CbGeAlD
Nandrolone decanoate—Irritability—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00554	CcSEcCtD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.00119	0.0123	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00543	CcSEcCtD
Nandrolone decanoate—AR—connective tissue—chronic obstructive pulmonary disease	0.00116	0.0795	CbGeAlD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00116	0.012	CbGpPWpGaD
Nandrolone decanoate—MAOB—bronchus—chronic obstructive pulmonary disease	0.00115	0.079	CbGeAlD
Nandrolone decanoate—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00115	0.00533	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.00112	0.0117	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.00111	0.0116	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00111	0.00513	CcSEcCtD
Nandrolone decanoate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00111	0.00513	CcSEcCtD
Nandrolone decanoate—AR—bronchus—chronic obstructive pulmonary disease	0.00109	0.0743	CbGeAlD
Nandrolone decanoate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00502	CcSEcCtD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.0112	CbGpPWpGaD
Nandrolone decanoate—AR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00106	0.0727	CbGeAlD
Nandrolone decanoate—MAOA—connective tissue—chronic obstructive pulmonary disease	0.00105	0.0721	CbGeAlD
Nandrolone decanoate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00484	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00102	0.0106	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00101	0.0105	CbGpPWpGaD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000999	0.0104	CbGpPWpGaD
Nandrolone decanoate—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000997	0.00462	CcSEcCtD
Nandrolone decanoate—Rash—Formoterol—chronic obstructive pulmonary disease	0.000986	0.00457	CcSEcCtD
Nandrolone decanoate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000986	0.00457	CcSEcCtD
Nandrolone decanoate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000985	0.00456	CcSEcCtD
Nandrolone decanoate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000985	0.00456	CcSEcCtD
Nandrolone decanoate—MAOA—bronchus—chronic obstructive pulmonary disease	0.000984	0.0674	CbGeAlD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000975	0.0101	CbGpPWpGaD
Nandrolone decanoate—Rash—Montelukast—chronic obstructive pulmonary disease	0.000966	0.00447	CcSEcCtD
Nandrolone decanoate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000965	0.00447	CcSEcCtD
Nandrolone decanoate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000931	0.00431	CcSEcCtD
Nandrolone decanoate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00093	0.00431	CcSEcCtD
Nandrolone decanoate—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000929	0.0043	CcSEcCtD
Nandrolone decanoate—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000929	0.0043	CcSEcCtD
Nandrolone decanoate—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00091	0.00421	CcSEcCtD
Nandrolone decanoate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000896	0.00415	CcSEcCtD
Nandrolone decanoate—MAOA—trachea—chronic obstructive pulmonary disease	0.000884	0.0605	CbGeAlD
Nandrolone decanoate—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000877	0.00406	CcSEcCtD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000874	0.00909	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000862	0.00897	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000859	0.00893	CbGpPWpGaD
Nandrolone decanoate—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000847	0.00392	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000846	0.0088	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000842	0.00876	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000797	0.00829	CbGpPWpGaD
Nandrolone decanoate—MAOB—lung—chronic obstructive pulmonary disease	0.000744	0.051	CbGeAlD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000726	0.00755	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000719	0.00748	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000708	0.00737	CbGpPWpGaD
Nandrolone decanoate—MAOB—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000706	0.00734	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000703	0.00732	CbGpPWpGaD
Nandrolone decanoate—AR—lung—chronic obstructive pulmonary disease	0.0007	0.0479	CbGeAlD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.0007	0.00728	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000673	0.00312	CcSEcCtD
Nandrolone decanoate—MAOA—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000658	0.00685	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000651	0.00302	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000648	0.00675	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000639	0.00665	CbGpPWpGaD
Nandrolone decanoate—MAOA—lung—chronic obstructive pulmonary disease	0.000635	0.0435	CbGeAlD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000635	0.0066	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000631	0.00657	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000623	0.00648	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000616	0.00641	CbGpPWpGaD
Nandrolone decanoate—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000616	0.00285	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000615	0.0064	CbGpPWpGaD
Nandrolone decanoate—Progesterone—CYP1A1—chronic obstructive pulmonary disease	0.000544	0.228	CrCbGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	0.000544	0.00566	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000536	0.00558	CbGpPWpGaD
Nandrolone decanoate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000534	0.00247	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000534	0.00247	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000531	0.00552	CbGpPWpGaD
Nandrolone decanoate—Progesterone—CYP1A2—chronic obstructive pulmonary disease	0.000525	0.22	CrCbGaD
Nandrolone decanoate—Norethindrone—ALB—chronic obstructive pulmonary disease	0.00052	0.218	CrCbGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000518	0.00539	CbGpPWpGaD
Nandrolone decanoate—Testosterone—CYP1A1—chronic obstructive pulmonary disease	0.000515	0.215	CrCbGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000511	0.00531	CbGpPWpGaD
Nandrolone decanoate—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000503	0.00233	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000499	0.00519	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—APIP—chronic obstructive pulmonary disease	0.000494	0.00514	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000489	0.00226	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000465	0.00484	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000443	0.00461	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000441	0.00459	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00044	0.00458	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000438	0.00456	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000436	0.00202	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000435	0.00453	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000432	0.00449	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000426	0.00443	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000421	0.00438	CbGpPWpGaD
Nandrolone decanoate—MAOA—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000407	0.00423	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000397	0.00413	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000391	0.00407	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000389	0.00405	CbGpPWpGaD
Nandrolone decanoate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000388	0.0018	CcSEcCtD
Nandrolone decanoate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000388	0.0018	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000386	0.00401	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000376	0.00391	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000374	0.0039	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.00386	CbGpPWpGaD
Nandrolone decanoate—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000366	0.00169	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000328	0.00341	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GC—chronic obstructive pulmonary disease	0.000319	0.00332	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	0.000312	0.00325	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—APIP—chronic obstructive pulmonary disease	0.00031	0.00323	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000303	0.00315	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000298	0.0031	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000296	0.00308	CbGpPWpGaD
Nandrolone decanoate—Testosterone—ALB—chronic obstructive pulmonary disease	0.000287	0.12	CrCbGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000273	0.00284	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000262	0.00272	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000241	0.0025	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000231	0.0024	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000227	0.00236	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000221	0.0023	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000216	0.00225	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000206	0.00214	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000205	0.00213	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0002	0.00209	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GC—chronic obstructive pulmonary disease	0.0002	0.00208	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000199	0.00207	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000196	0.00203	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000195	0.00203	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000195	0.00203	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00019	0.00197	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000188	0.00196	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000186	0.00193	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000181	0.00189	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000176	0.00183	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000174	0.00181	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000173	0.0018	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000172	0.00179	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000172	0.00179	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000169	0.00176	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000167	0.00174	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000161	0.00168	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000157	0.00163	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000153	0.00159	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000148	0.00154	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00151	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000144	0.0015	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	0.000144	0.00149	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000142	0.00148	CbGpPWpGaD
Nandrolone decanoate—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	0.000136	0.00142	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000135	0.00141	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	0.000134	0.00139	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000121	0.00126	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000119	0.00124	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000111	0.00115	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000109	0.00114	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000108	0.00112	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000107	0.00111	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000105	0.0011	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.00109	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CTGF—chronic obstructive pulmonary disease	9.85e-05	0.00103	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.82e-05	0.00102	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.61e-05	0.001	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.08e-05	0.000945	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.85e-05	0.000921	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.57e-05	0.000788	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.47e-05	0.000777	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.38e-05	0.000768	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.28e-05	0.000758	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ALB—chronic obstructive pulmonary disease	7.14e-05	0.000743	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.96e-05	0.000724	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.83e-05	0.000711	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.79e-05	0.000706	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.6e-05	0.000686	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	6.55e-05	0.000681	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.43e-05	0.000669	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ALB—chronic obstructive pulmonary disease	4.48e-05	0.000466	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.37e-05	0.000455	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-05	0.000446	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.18e-05	0.000435	CbGpPWpGaD
